Latest Breaking News On - Nuclear medicine theranostics - Page 1 : comparemela.com

Telix Pharmaceuticals (ASX.TLX) has announced that its Japanese subsidiary (Telix Japan) and partner Kanazawa University have received Clinical Trial.

Shintaro nishimuraSeigo kinuyaTelix pharmaceuticalsKanazawa universityKanazawa advanced medical centerNational conference for nuclear medicine theranosticsInnovative clinical research centerJapanese society of nuclear medicineJapanese pharmaceuticalsProfessor of nuclear medicineDepartment of nuclear medicineTelix pharmaceuticals japanKanazawa university hospitalKanazawa university departments of nuclear medicineDevices agencyTelix japan